Paul Rutgeerts Selected Research

Crohn Disease (Crohn's Disease)

1/2021	Rates of Postoperative Recurrence of Crohn's Disease and Effects of Immunosuppressive and Biologic Therapies.
1/2020	Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn's Disease.
1/2020	IM-UNITI: Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease.
10/2019	Effects of Ustekinumab on Histologic Disease Activity in Patients With Crohn's Disease.
7/2019	Gene and Mirna Regulatory Networks During Different Stages of Crohn's Disease.
5/2019	Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn's Disease Studies.
10/2018	Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn's Disease.
12/2017	Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial.
10/2017	Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease.
9/2017	Vedolizumab Induces Long-term Mucosal Healing in Patients With Crohn's Disease and Ulcerative Colitis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul Rutgeerts Research Topics

Disease

159	Crohn Disease (Crohn's Disease) 01/2021 - 01/2002
91	Ulcerative Colitis 09/2019 - 02/2002
81	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019 - 02/2002
38	Inflammation (Inflammations) 01/2018 - 08/2002
22	Infections 01/2020 - 06/2005
15	Necrosis 12/2017 - 10/2002
12	Colitis 02/2013 - 09/2002
10	Body Weight (Weight, Body) 09/2019 - 01/2003
9	Neoplasms (Cancer) 09/2017 - 12/2007
8	Fistula 04/2013 - 02/2003
7	Rheumatoid Arthritis 01/2015 - 05/2002
6	Pouchitis 01/2017 - 01/2008
6	Disease Progression 01/2016 - 09/2009
6	Sclerosing Cholangitis 02/2012 - 04/2006
5	Ulcer 12/2017 - 04/2002
5	Pathologic Constriction (Stenosis) 02/2010 - 01/2004
4	Abdominal Pain (Pain, Abdominal) 04/2016 - 08/2013
4	Fibrosis (Cirrhosis) 01/2013 - 02/2003
3	Tuberculosis (Tuberculoses) 06/2014 - 10/2009
3	Ileitis 12/2013 - 09/2002
2	Hypersensitivity (Allergy) 04/2016 - 08/2010
2	Dysbiosis 08/2014 - 05/2011
2	Nausea 12/2013 - 02/2003
2	Proctitis 07/2013 - 10/2002
2	Opportunistic Infections (Opportunistic Infection) 05/2012 - 09/2008
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 11/2011 - 12/2005
2	Colorectal Neoplasms (Colorectal Cancer) 01/2011 - 02/2010

Drug/Important Bio-Agent (IBA)

87	Infliximab (Remicade)FDA Link 01/2018 - 02/2002
37	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 08/2002
25	AntibodiesIBA 01/2016 - 08/2002
23	Monoclonal AntibodiesIBA 10/2018 - 01/2003
19	Adalimumab (Humira)FDA Link 01/2020 - 07/2005
15	Biological ProductsIBA 11/2015 - 02/2003
15	Azathioprine (Imuran)FDA LinkGeneric 08/2015 - 02/2002
14	C-Reactive ProteinIBA 12/2017 - 09/2002
13	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 05/2002
13	CytokinesIBA 10/2015 - 08/2002
13	Phenobarbital (Luminal)FDA Link 02/2010 - 05/2004
12	Pharmaceutical PreparationsIBA 01/2019 - 02/2002
12	SteroidsIBA 01/2011 - 02/2003
10	Tumor Necrosis Factor InhibitorsIBA 10/2018 - 08/2006
10	Biomarkers (Surrogate Marker)IBA 12/2017 - 03/2005
9	golimumab FDA Link 09/2019 - 01/2014
9	Certolizumab Pegol FDA Link 04/2013 - 09/2005
8	Immunologic Factors (Immunomodulators)IBA 12/2017 - 02/2009
8	Proteins (Proteins, Gene)FDA Link 11/2015 - 07/2006
7	Butyrates (Butyrate)IBA 02/2015 - 03/2009
6	Ustekinumab (CNTO 1275)FDA Link 01/2020 - 10/2008
6	vedolizumabIBA 09/2017 - 02/2005
6	IntegrinsIBA 01/2017 - 01/2003
6	Interleukin-12 (IL 12)IBA 11/2016 - 10/2002
6	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2011 - 02/2003
6	Natalizumab (Tysabri)FDA Link 01/2009 - 01/2003
5	Sodium Glutamate (Accent)IBA 11/2014 - 05/2002
5	Messenger RNA (mRNA)IBA 01/2014 - 03/2007
5	Mesalamine (Mesalazine)FDA LinkGeneric 07/2013 - 10/2002
5	Interferon-gamma (Interferon, gamma)IBA 02/2010 - 10/2002
5	Immunoglobulin G (IgG)IBA 12/2007 - 06/2005
4	Leukocyte L1 Antigen Complex (Calgranulin)IBA 12/2017 - 09/2004
4	AntigensIBA 06/2011 - 11/2007
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 02/2011 - 08/2004
3	Interleukin-23 (Interleukin 23)IBA 11/2016 - 10/2008
3	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2013 - 01/2006
3	AutoantibodiesIBA 02/2011 - 11/2004
3	purineIBA 12/2010 - 07/2009
3	Immunoglobulin Fab FragmentsIBA 04/2010 - 09/2005
3	Immunosuppressive Agents (Immunosuppressants)IBA 02/2010 - 09/2008
3	Anti-Bacterial Agents (Antibiotics)IBA 02/2010 - 04/2005
3	PorinsIBA 06/2008 - 10/2007
3	EpitopesIBA 06/2008 - 10/2007
3	Methotrexate (Mexate)FDA LinkGeneric 09/2007 - 02/2002
2	MicroRNAs (MicroRNA)IBA 07/2019 - 01/2014
2	InterleukinsIBA 10/2018 - 10/2002
2	InterferonsIBA 07/2017 - 10/2002
2	etrolizumabIBA 02/2016 - 07/2014
2	Genetic Markers (Genetic Marker)IBA 01/2016 - 06/2010
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 12/2015 - 07/2014
2	LipocalinsIBA 12/2015 - 07/2014
2	InflammasomesIBA 11/2015 - 09/2009
2	NucleotidesIBA 03/2015 - 11/2007
2	Interleukin-8 (Interleukin 8)IBA 02/2015 - 04/2011
2	Transcription Factors (Transcription Factor)IBA 09/2014 - 02/2011
2	EnzymesIBA 07/2014 - 02/2011
2	Sulfides (Thioethers)IBA 04/2013 - 12/2012
2	Inulin FDA Link 01/2013 - 06/2012
2	oligofructoseIBA 01/2013 - 06/2012
2	Antimicrobial PeptidesIBA 01/2012 - 11/2009
2	AutoantigensIBA 06/2011 - 11/2007
2	ChemokinesIBA 04/2011 - 07/2004
2	Chemokine ReceptorsIBA 04/2011 - 04/2006
2	DNA (Deoxyribonucleic Acid)IBA 01/2011 - 07/2003
2	Indomethacin (Indometacin)FDA LinkGeneric 08/2010 - 07/2005

Therapy/Procedure

106	Therapeutics 10/2019 - 02/2002
12	Colectomy 01/2017 - 09/2004
9	Biological Therapy 01/2021 - 02/2002
4	Restorative Proctocolectomy 01/2017 - 01/2008
3	Remission Induction 07/2017 - 02/2006
3	Aftercare (After-Treatment) 10/2009 - 08/2002
2	Investigational Therapies (Experimental Therapy) 01/2017 - 01/2014
2	Transplantation 04/2016 - 02/2012